AIM - AIM Notice - 09/10/2026

Focus Xplore

09/10/2026 08:00

		
		
		
		
		
	
	
RNS Number : 2424Y
  
AIM
  
09 October 2026
  
 

		

			

				NOTICE
			
			

				 
			
			

				09/10/2026 - 08:00
			
			

				 
			
			

				The London Stock Exchange admits the following securities to trading on AIM:
			
			

				 
			
			

				

					

						

							Arecor Therapeutics plc
						
					
				
				

					

						

							191,176
						
					
					

						

							ORDINARY SHARES OF GBP0.01 EACH, FULLY PAID
						
					
					

						

							(BMWLM97)(GB00BMWLM973)
						
					
				
			
			

				 
			
			

				

					

						

							Avacta Group Plc
						
					
				
				

					

						

							18,382,353
						
					
					

						

							ORDINARY SHARES OF 10P EACH, FULLY PAID
						
					
					

						

							(BYYW9G8)(GB00BYYW9G87)
						
					
				
			
			

				 
			
			

				

					

						

							Eagle Eye Solutions Group PLC
						
					
				
				

					

						

							1,000
						
					
					

						

							ORDINARY SHARES OF 1P EACH FULLY PAID
						
					
					

						

							(BKF1YD8)(GB00BKF1YD83)
						
					
				
			
			

				 
			
			

				

					

						

							Focus Xplore PLC
						
					
				
				

					

						

							3,077,775,176
						
					
					

						

							ORDINARY SHARES OF GBP0.0001 EACH, FULLY PAID
						
					
					

						

							(BSNBL02)(GB00BSNBL022)
						
					
				
			
			

				 
			
			

				

					

						

							Galantas Gold Corporation
						
					
				
				

					

						

							250,000
						
					
					

						

							COMMON SHARES OF NO PAR VALUE, FULLY PAID
						
					
					

						

							(BM962Z1)(CA36315W3012)
						
					
				
			
			

				 
			
			

				

					

						

							Globalworth Real Estate Investments Limited
						
					
				
				

					

						

							9,232,888
						
					
					

						

							ORDINARY SHARES OF NO PAR VALUE EACH; FULLY PAID
						
					
					

						

							(B979FD0)(GG00B979FD04)
						
					
				
			
			

				 
			
			

				

					

						

							Kazera Global Plc
						
					
				
				

					

						

							11,098,122
						
					
					

						

							ORDINARY SHARES OF 0.1P EACH, FULLY PAID
						
					
					

						

							(B830HW3)(GB00B830HW33)
						
					
				
			
			

				 
			
			

				

					

						

							MedPal AI plc
						
					
				
				

					

						

							3,700,000
						
					
					

						

							ORDINARY SHARES OF 0.02P EACH, FULLY PAID
						
					
					

						

							(BTRC7N3)(GB00BTRC7N37)
						
					
				
			
			

				 
			
			

				

					

						

							MKANGO MAGNETIC MATERIALS LIMITED
						
					
				
				

					

						

							600,000
						
					
					

						

							COMMON SHARES OF NO PAR VALUE FULLY PAID (DI)
						
					
					

						

							(BTSK7N6)(CA60701M1077)
						
					
				
			
			

				 
			
			

				

					

						

							Norman Broadbent PLC
						
					
				
				

					

						

							17,485
						
					
					

						

							ORDINARY SHARES OF 5P EACH, FULLY PAID
						
					
					

						

							(BTHYM34)(GB00BTHYM345)
						
					
				
			
			

				 
			
			

				

					

						

							Premier African Minerals Limited
						
					
				
				

					

						

							27,522,935,780
						
					
					

						

							ORDINARY SHARES OF NIL PAR VALUE FULLY PAID (DI)
						
					
					

						

							(BNVY1J7)(VGG7223M1187)
						
					
				
			
			

				 
			
			

				If you have any queries or require further information, please contact Market Operations on 020 7797 4310.
			
			

				 
			
		
	
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
AMOBUBDGRBGDGLI